Free tool
Stocks near their 52-week high
We cover 26 companies trading within 5% of their own 52-week high. The median market value in the group is $26.77B. Across the group, the median move over the past trading day is +0.11%. 100% of the 26 with a 200-day average trade above it. Price change over the past year runs from +10.3% to +97.3% across the middle 80 percent of the group, with a median of +38.3%.
Other lists in this group
Table
26 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NEM | Newmont Corporation | $138.67B | Large cap | +83.73% |
| FCX | Freeport-McMoRan Inc. | $113.45B | Large cap | +81.57% |
| PSX | Phillips 66 | $96.65B | Large cap | +87.07% |
| DB | Deutsche Bank Aktiengesellschaft | $75.59B | Large cap | +14.81% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| NDAQ | Nasdaq, Inc. | $55.60B | Large cap | +5.83% |
| EA | Electronic Arts Inc | $52.93B | Large cap | +21.84% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| SN | SharkNinja, Inc. | $26.56B | Large cap | +56.75% |
| KSPI | Joint Stock Company Kaspi.kz | $20.46B | Large cap | +18.99% |
| NDSN | Nordson Corporation | $18.64B | Large cap | +49.78% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| SJM | The J. M. Smucker Company | $13.99B | Large cap | +27.78% |
| SEIC | SEI Investments Company | $13.30B | Large cap | +23.14% |
| CHYM | Chime Financial, Inc. | $12.55B | Large cap | +26.43% |
| MANH | Manhattan Associates, Inc. | $12.42B | Large cap | −2.65% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| PAYC | Paycom Software, Inc. | $10.47B | Large cap | +2.73% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.